Baxter International Inc. (BAX)
NYSE: BAX · IEX Real-Time Price · USD
40.13
-0.10 (-0.25%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Baxter International Revenue
In the year 2023, Baxter International had annual revenue of $14.81B with 2.12% growth. Revenue in the quarter ending December 31, 2023 was $3.89B with 3.74% year-over-year growth.
Revenue (ttm)
$14.81B
Revenue Growth
+2.12%
P/S Ratio
1.38
Revenue / Employee
$246,883
Employees
60,000
Market Cap
20.39B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.81B | 307.00M | 2.12% |
Dec 31, 2022 | 14.51B | 2.36B | 19.43% |
Dec 31, 2021 | 12.15B | 473.00M | 4.05% |
Dec 31, 2020 | 11.67B | 311.00M | 2.74% |
Dec 31, 2019 | 11.36B | 263.00M | 2.37% |
Dec 31, 2018 | 11.10B | 515.00M | 4.87% |
Dec 31, 2017 | 10.58B | 421.00M | 4.14% |
Dec 31, 2016 | 10.16B | 195.00M | 1.96% |
Dec 31, 2015 | 9.97B | -751.00M | -7.01% |
Dec 31, 2014 | 10.72B | 1.31B | 13.87% |
Dec 31, 2013 | 9.41B | -4.52B | -32.46% |
Dec 31, 2012 | 13.94B | 43.00M | 0.31% |
Dec 31, 2011 | 13.89B | 1.05B | 8.18% |
Dec 31, 2010 | 12.84B | 281.00M | 2.24% |
Dec 31, 2009 | 12.56B | 214.00M | 1.73% |
Dec 31, 2008 | 12.35B | 1.09B | 9.63% |
Dec 31, 2007 | 11.26B | 885.00M | 8.53% |
Dec 31, 2006 | 10.38B | 529.00M | 5.37% |
Dec 31, 2005 | 9.85B | 340.00M | 3.58% |
Dec 31, 2004 | 9.51B | 605.00M | 6.79% |
Dec 31, 2003 | 8.90B | 805.00M | 9.94% |
Dec 31, 2002 | 8.10B | 757.00M | 10.31% |
Dec 31, 2001 | 7.34B | 645.00M | 9.63% |
Dec 31, 2000 | 6.70B | 317.00M | 4.97% |
Dec 31, 1999 | 6.38B | 674.00M | 11.81% |
Dec 31, 1998 | 5.71B | 447.00M | 8.50% |
Dec 31, 1997 | 5.26B | -179.00M | -3.29% |
Dec 31, 1996 | 5.44B | 390.00M | 7.73% |
Dec 31, 1995 | 5.05B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cardinal Health | 216.15B |
Molina Healthcare | 35.85B |
Koninklijke Philips | 20.19B |
Zimmer Biomet Holdings | 7.39B |
STERIS | 5.41B |
Illumina | 4.50B |
BioNTech SE | 4.24B |
Align Technology | 3.86B |
BAX News
- 4 days ago - Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers - Business Wire
- 5 days ago - Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO - Business Wire
- 17 days ago - Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. - Business Wire
- 17 days ago - Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors - Business Wire
- 27 days ago - Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy - Business Wire
- 4 weeks ago - Baxter to Host Annual Meeting of Stockholders in Virtual Format - Business Wire
- 2 months ago - Baxter to Present at Raymond James 45th Annual Institutional Investors Conference - Business Wire
- 2 months ago - Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation - GlobeNewsWire